Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DM8X5Q1)

Drug Name	CP101 DM8X5Q1
Drug Type	Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Clostridium infection	DISKYOX0	1A04	Phase 2	[1]
Autism spectrum disorder	DISXK8NV	6A02	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03497806) Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT03829878) Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) (SPROUT). U.S. National Institutes of Health.